AGFA Gevaert NV (AGFB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, AGFA Gevaert NV (AGFB) has a cash flow conversion efficiency ratio of 0.120x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€35.00 Million ≈ $40.92 Million USD) by net assets (€291.00 Million ≈ $340.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AGFB defensive interval ratio to measure how many days the company can operate on defensive assets alone.
AGFA Gevaert NV - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how AGFA Gevaert NV's cash flow conversion efficiency has evolved over time, based on yearly financial data.
AGFA Gevaert NV Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AGFA Gevaert NV ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ONDINE BIOMEDICAL INC.CDI
F:VF5
|
N/A |
|
Nature and Environment Co. Ltd
KQ:043910
|
-0.061x |
|
Research Solutions Inc
NASDAQ:RSSS
|
0.080x |
|
Fission 3.0 Corp
V:FUU
|
-0.019x |
|
LBG MEDIA PLC LS -001
F:S83
|
0.059x |
|
ActRO Co. Ltd
KQ:290740
|
-0.024x |
|
Wintergreen Acquisition Corp. Ordinary Shares
NASDAQ:WTG
|
-0.002x |
|
Lifetime Brands Inc
NASDAQ:LCUT
|
-0.120x |
Annual Cash Flow Conversion Efficiency for AGFA Gevaert NV (2000–2024)
The table below shows the annual cash flow conversion efficiency of AGFA Gevaert NV from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see AGFA Gevaert NV market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €325.00 Million ≈ $379.96 Million |
€-4.00 Million ≈ $-4.68 Million |
-0.012x | +83.75% |
| 2023-12-31 | €396.00 Million ≈ $462.97 Million |
€-30.00 Million ≈ $-35.07 Million |
-0.076x | +57.50% |
| 2022-12-31 | €561.00 Million ≈ $655.87 Million |
€-100.00 Million ≈ $-116.91 Million |
-0.178x | -5.42% |
| 2021-12-31 | €686.00 Million ≈ $802.01 Million |
€-116.00 Million ≈ $-135.62 Million |
-0.169x | +31.37% |
| 2020-12-31 | €621.00 Million ≈ $726.01 Million |
€-153.00 Million ≈ $-178.87 Million |
-0.246x | -126.04% |
| 2019-12-31 | €130.00 Million ≈ $151.98 Million |
€123.00 Million ≈ $143.80 Million |
0.946x | +723.60% |
| 2018-12-31 | €290.00 Million ≈ $339.04 Million |
€-44.00 Million ≈ $-51.44 Million |
-0.152x | -219.43% |
| 2017-12-31 | €307.00 Million ≈ $358.92 Million |
€39.00 Million ≈ $45.60 Million |
0.127x | -77.46% |
| 2016-12-31 | €252.00 Million ≈ $294.61 Million |
€142.00 Million ≈ $166.01 Million |
0.563x | +1.35% |
| 2015-12-31 | €268.00 Million ≈ $313.32 Million |
€149.00 Million ≈ $174.20 Million |
0.556x | -46.24% |
| 2014-12-31 | €146.00 Million ≈ $170.69 Million |
€151.00 Million ≈ $176.53 Million |
1.034x | +255.70% |
| 2013-12-31 | €368.00 Million ≈ $430.23 Million |
€107.00 Million ≈ $125.09 Million |
0.291x | +767.74% |
| 2012-12-31 | €955.00 Million ≈ $1.12 Billion |
€32.00 Million ≈ $37.41 Million |
0.034x | +223.48% |
| 2011-12-31 | €995.00 Million ≈ $1.16 Billion |
€-27.00 Million ≈ $-31.57 Million |
-0.027x | -112.27% |
| 2010-12-31 | €1.06 Billion ≈ $1.24 Billion |
€235.00 Million ≈ $274.74 Million |
0.221x | -39.83% |
| 2009-12-31 | €724.00 Million ≈ $846.43 Million |
€266.00 Million ≈ $310.98 Million |
0.367x | +219.32% |
| 2008-12-31 | €704.00 Million ≈ $823.05 Million |
€81.00 Million ≈ $94.70 Million |
0.115x | -4.76% |
| 2007-12-31 | €894.00 Million ≈ $1.05 Billion |
€108.00 Million ≈ $126.26 Million |
0.121x | +5.68% |
| 2006-12-31 | €936.00 Million ≈ $1.09 Billion |
€107.00 Million ≈ $125.09 Million |
0.114x | +44.29% |
| 2005-12-31 | €1.03 Billion ≈ $1.21 Billion |
€82.00 Million ≈ $95.87 Million |
0.079x | -57.08% |
| 2004-12-31 | €443.72 Million ≈ $518.76 Million |
€81.90 Million ≈ $95.75 Million |
0.185x | -51.45% |
| 2003-12-31 | €1.37 Billion ≈ $1.61 Billion |
€522.00 Million ≈ $610.27 Million |
0.380x | -13.76% |
| 2002-12-31 | €1.39 Billion ≈ $1.62 Billion |
€611.00 Million ≈ $714.32 Million |
0.441x | -24.26% |
| 2001-12-31 | €1.27 Billion ≈ $1.48 Billion |
€738.00 Million ≈ $862.80 Million |
0.582x | +110.51% |
| 2000-12-31 | €1.58 Billion ≈ $1.84 Billion |
€436.00 Million ≈ $509.73 Million |
0.276x | -- |
About AGFA Gevaert NV
Agfa-Gevaert NV develops, manufactures, and markets various analog and digital systems worldwide. It operates through four segments: HealthCare IT, Digital Print and Chemicals, Radiology Solutions, and Contractor Operations and Services (CONOPS). The Healthcare IT segment provides healthcare's enterprise imaging platform. The Digital Print & Chemicals segment offers printers, inks, and software f… Read more